Recently, researchers have observed that soluble CD95L is overexpressed in the serum of patients with triple-negative breast cancer or SLE, which affects the severity of these diseases by activating nonapoptotic signaling pathways and promoting the metastasis or accumulation of certain T cell subsets in damaged organs (70–72). This evidence concerns the gene FASLG and systemic lupus erythematosus.